TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/5/23 16:49 | 1/3/23 | CMMB | Chemomab Therapeutics Ltd. | Health | Drug | Pharmaceutical Preparations | Orbimed Israel Gp Ltd. | L3 | T | S | -1,208 | 3.58 | 0 | -337 | -13 | 2,241 | I | ||||||||||||||||
6/25/21 19:08 | 6/23/21 | NMTR | 9 Meters Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Orbimed Israel Gp Ltd. | NY | T | S.m | -20,933 | 1.22 | 0 | -17,151 | -67 | 8,598 | I | |||||||||||||||
12/4/20 17:17 | 12/2/20 | NVUS | Novus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Orbimed Israel Gp Ltd. | L3 | T | S | -2,229 | 21.60 | 0 | -103 | -58 | 74 | I | |||||||||||||||
5/6/19 17:30 | 5/2/19 | NVUS | Novus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Orbimed Israel Gp Ltd. | L3 | DT | P.d | 2,003 | 3.10 | 0 | 646 | 25 | 3,183 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |